314 related articles for article (PubMed ID: 33012199)
1. Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex.
Zemskova M; McClain N; Niihori M; Varghese MV; James J; Rafikov R; Rafikova O
Hypertension; 2020 Dec; 76(6):1787-1799. PubMed ID: 33012199
[TBL] [Abstract][Full Text] [Related]
2. Gender Difference in Damage-Mediated Signaling Contributes to Pulmonary Arterial Hypertension.
Rafikov R; Nair V; Sinari S; Babu H; Sullivan JC; Yuan JX; Desai AA; Rafikova O
Antioxid Redox Signal; 2019 Nov; 31(13):917-932. PubMed ID: 30652485
[No Abstract] [Full Text] [Related]
3. HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling.
Wang J; Tian XT; Peng Z; Li WQ; Cao YY; Li Y; Li XH
Vascul Pharmacol; 2019 Jun; 117():35-44. PubMed ID: 30610955
[TBL] [Abstract][Full Text] [Related]
4. HIMF (Hypoxia-Induced Mitogenic Factor) Signaling Mediates the HMGB1 (High Mobility Group Box 1)-Dependent Endothelial and Smooth Muscle Cell Crosstalk in Pulmonary Hypertension.
Lin Q; Fan C; Gomez-Arroyo J; Van Raemdonck K; Meuchel LW; Skinner JT; Everett AD; Fang X; Macdonald AA; Yamaji-Kegan K; Johns RA
Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2505-2519. PubMed ID: 31597444
[TBL] [Abstract][Full Text] [Related]
5. ERK/Drp1-dependent mitochondrial fission contributes to HMGB1-induced autophagy in pulmonary arterial hypertension.
Feng W; Wang J; Yan X; Zhang Q; Chai L; Wang Q; Shi W; Chen Y; Liu J; Qu Z; Li S; Xie X; Li M
Cell Prolif; 2021 Jun; 54(6):e13048. PubMed ID: 33948998
[TBL] [Abstract][Full Text] [Related]
6. High-mobility group box-1 induces vascular remodelling processes via c-Jun activation.
Zabini D; Crnkovic S; Xu H; Tscherner M; Ghanim B; Klepetko W; Olschewski A; Kwapiszewska G; Marsh LM
J Cell Mol Med; 2015 May; 19(5):1151-61. PubMed ID: 25726846
[TBL] [Abstract][Full Text] [Related]
7. HMGB1-induced activation of ER stress contributes to pulmonary artery hypertension in vitro and in vivo.
Zhang Q; Chen Y; Wang Q; Wang Y; Feng W; Chai L; Liu J; Li D; Chen H; Qiu Y; Shen N; Shi X; Xie X; Li M
Respir Res; 2023 Jun; 24(1):149. PubMed ID: 37268944
[TBL] [Abstract][Full Text] [Related]
8. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
[No Abstract] [Full Text] [Related]
9. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
10. RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension.
Jia D; He Y; Zhu Q; Liu H; Zuo C; Chen G; Yu Y; Lu A
Cardiovasc Res; 2017 May; 113(6):586-597. PubMed ID: 28407046
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
12. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism.
Liu Y; Sun Z; Zhu J; Xiao B; Dong J; Li X
J Cell Physiol; 2018 Jun; 233(6):4801-4814. PubMed ID: 29150946
[TBL] [Abstract][Full Text] [Related]
14. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
[TBL] [Abstract][Full Text] [Related]
15. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
16. HMGB1 down-regulation mediates terameprocol vascular anti-proliferative effect in experimental pulmonary hypertension.
Nogueira-Ferreira R; Ferreira-Pinto MJ; Silva AF; Vitorino R; Justino J; Costa R; Moreira-Gonçalves D; Quignard JF; Ducret T; Savineau JP; Leite-Moreira AF; Ferreira R; Henriques-Coelho T
J Cell Physiol; 2017 Nov; 232(11):3128-3138. PubMed ID: 28036116
[TBL] [Abstract][Full Text] [Related]
17. The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice.
Batool M; Berghausen EM; Zierden M; Vantler M; Schermuly RT; Baldus S; Rosenkranz S; Ten Freyhaus H
Basic Res Cardiol; 2020 Nov; 115(6):68. PubMed ID: 33188479
[TBL] [Abstract][Full Text] [Related]
18. Growth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin.
Kinoshita D; Shishido T; Takahashi T; Yokoyama M; Sugai T; Watanabe K; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Kishida S; Kadomatsu K; Abe JI; Takeishi Y; Konta T; Kubota I; Watanabe M
Sci Rep; 2020 Jun; 10(1):10345. PubMed ID: 32587339
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
20. Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
Vitry G; Paulin R; Grobs Y; Lampron MC; Shimauchi T; Lemay SE; Tremblay E; Habbout K; Awada C; Bourgeois A; Nadeau V; Paradis R; Breuils-Bonnet S; Roux-Dalvai F; Orcholski M; Potus F; Provencher S; Boucherat O; Bonnet S
Am J Respir Crit Care Med; 2021 Mar; 203(5):614-627. PubMed ID: 33021405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
